Elevated serum levels of FGF-2, NGF and IGF-1 in patients with manic episode of bipolar disorder

[1]  M. Amore,et al.  VEGF plasma level variations in duloxetine-treated patients with major depression. , 2013, Journal of affective disorders.

[2]  Yong-Ku Kim,et al.  High insulin-like growth factor-1 in patients with bipolar I disorder: a trait marker? , 2013, Journal of affective disorders.

[3]  Chih‐Yao Chen,et al.  Changes in maternal serum insulin‐like growth factor‐I during pregnancy and its relationship to maternal anthropometry , 2013, Journal of the Chinese Medical Association : JCMA.

[4]  S. R. Azua,et al.  Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[5]  S. Calza,et al.  Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients. , 2013, Pharmacological research.

[6]  D. Chuang,et al.  Therapeutic Potential of Mood Stabilizers Lithium and Valproic Acid: Beyond Bipolar Disorder , 2013, Pharmacological Reviews.

[7]  A. Nierenberg,et al.  Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder , 2012, Acta psychiatrica Scandinavica.

[8]  E. Obuchowicz,et al.  Vascular endothelial growth factor (VEGF) and its role in the central nervous system: A new element in the neurotrophic hypothesis of antidepressant drug action , 2012, Neuropeptides.

[9]  P. Carmeliet,et al.  The Neurovascular Link in Health and Disease: Molecular Mechanisms and Therapeutic Implications , 2011, Neuron.

[10]  Z. Janka,et al.  Impaired nerve growth factor homeostasis in patients with bipolar disorder , 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[11]  Tamar Licht,et al.  Reversible modulations of neuronal plasticity by VEGF , 2011, Proceedings of the National Academy of Sciences.

[12]  A. Tsatsakis,et al.  Time interval from cigarette smoke exposure to blood donation and markers of inflammation: should a smoking cut-off be designated? , 2010, Xenobiotica; the fate of foreign compounds in biological systems.

[13]  P. Carmeliet,et al.  The neurovascular link in health and disease: an update. , 2009, Trends in molecular medicine.

[14]  Karl H. Plate,et al.  Angiogenesis after cerebral ischemia , 2009, Acta Neuropathologica.

[15]  H. Blumberg,et al.  Influence of Vascular Endothelial Growth Factor Variation on Human Hippocampus Morphology , 2008, Biological Psychiatry.

[16]  R. Duman,et al.  Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus , 2008, Proceedings of the National Academy of Sciences.

[17]  B. Frey,et al.  Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder , 2008, Expert review of neurotherapeutics.

[18]  P. Carmeliet,et al.  Neurovascular signalling defects in neurodegeneration , 2008, Nature Reviews Neuroscience.

[19]  I. Torres-Aleman,et al.  Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects , 2007, Molecular Psychiatry.

[20]  J. Folch,et al.  Circulating nerve growth factor levels in relation to obesity and the metabolic syndrome in women. , 2007, European journal of endocrinology.

[21]  Jie Du,et al.  Mechanical Stretch Simulates Proliferation of Venous Smooth Muscle Cells Through Activation of the Insulin-Like Growth Factor-1 Receptor , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[22]  Jun-Feng Wang,et al.  Decreased expression of insulin-like growth factor binding protein 2 in the prefrontal cortex of subjects with bipolar disorder and its regulation by lithium treatment , 2007, Brain Research.

[23]  J. Kapfhammer,et al.  Basic Fibroblast Growth Factor Modulates Density of Blood Vessels and Preserves Tight Junctions in Organotypic Cortical Cultures of Mice: A New In Vitro Model of the Blood–Brain Barrier , 2007, The Journal of Neuroscience.

[24]  R. Duman,et al.  VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants , 2007, Proceedings of the National Academy of Sciences.

[25]  P. Sedgwick,et al.  Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder , 2006, Brain Research Bulletin.

[26]  I. Torres-Aleman,et al.  Serum insulin-like growth factor I in brain function. , 2006, The Keio journal of medicine.

[27]  H. Manji,et al.  The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers , 2006, Current opinion in psychiatry.

[28]  C. Carter,et al.  Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging , 2005, Ageing Research Reviews.

[29]  F. Fumagalli,et al.  Emerging role of the FGF system in psychiatric disorders. , 2005, Trends in pharmacological sciences.

[30]  E G Jones,et al.  Dysregulation of the fibroblast growth factor system in major depression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  K. Hashimoto,et al.  Critical role of brain-derived neurotrophic factor in mood disorders , 2004, Brain Research Reviews.

[32]  R. Duman,et al.  Gene Profile of Electroconvulsive Seizures: Induction of Neurotrophic and Angiogenic Factors , 2003, The Journal of Neuroscience.

[33]  H. Manji,et al.  The Role of the Extracellular Signal-Regulated Kinase Signaling Pathway in Mood Modulation , 2003, The Journal of Neuroscience.

[34]  K. Unsicker,et al.  Functions of Fibroblast Growth Factor (FGF)-2 and FGF-5 in Astroglial Differentiation and Blood-Brain Barrier Permeability: Evidence from Mouse Mutants , 2003, The Journal of Neuroscience.

[35]  Bernhard Reuss,et al.  Fibroblast growth factors and their receptors in the central nervous system , 2003, Cell and Tissue Research.

[36]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[37]  K. Jin,et al.  Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  E. Alleva,et al.  Stress and nerve growth factor Findings in animal models and humans , 2002, Pharmacology Biochemistry and Behavior.

[39]  F. Fumagalli,et al.  Modulation of fibroblast growth factor-2 by stress and corticosteroids: from developmental events to adult brain plasticity , 2001, Brain Research Reviews.

[40]  J. O’Kusky,et al.  Insulin-Like Growth Factor-I Promotes Neurogenesis and Synaptogenesis in the Hippocampal Dentate Gyrus during Postnatal Development , 2000, The Journal of Neuroscience.

[41]  G. Rajkowska,et al.  Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells , 2000, Biological Psychiatry.

[42]  F. Angelucci,et al.  Data and hypotheses on the role of nerve growth factor and other neurotrophins in psychiatric disorders. , 2000, Medical hypotheses.

[43]  Daniel J Buysse,et al.  Insulin-like growth factor 1 and growth hormone binding protein in depression: a preliminary communication. , 1999, Journal of psychiatric research.

[44]  S. Bonini,et al.  The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases , 1997, Allergy.

[45]  E. Nestler,et al.  A molecular and cellular theory of depression. , 1997, Archives of general psychiatry.

[46]  J. Fiddes,et al.  Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. , 1986, Science.

[47]  Yong-Ku Kim,et al.  Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders. , 2012, Journal of affective disorders.

[48]  R. McIntyre,et al.  Insulin, Insulin-Like Growth Factors and Incretins , 2008, CNS drugs.

[49]  C. Pittenger,et al.  Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms , 2008, Neuropsychopharmacology.

[50]  F. Gaughran,et al.  Hippocampal FGF2 and FGFR1 mRNA and protein expression in major depression, schizophrenia and bipolar disorder , 2006 .

[51]  F. Sun,et al.  Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor , 2005, Journal of neuroscience research.

[52]  G. Mckhann.  VEGF Links Hippocampal Activity with Neurogenesis, Learning, and Memory. , 2005, Neurosurgery.

[53]  S. Yamada,et al.  Blood-Brain Barrier Transport of 125I-Labeled Basic Fibroblast Growth Factor , 2004, Pharmaceutical Research.

[54]  M. Sofroniew,et al.  Nerve growth factor signaling, neuroprotection, and neural repair. , 2001, Annual review of neuroscience.